Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath Sells 94 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jamie Samath also recently made the following trade(s):

• On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The shares were sold at an average price of $540.15, for a total value of $145,840.50.
• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.00, for a total value of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The stock was sold at an average price of $542.06, for a total value of $58,542.48.
• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total value of $145,230.41.

Intuitive Surgical Stock Up 1.3 %

ISRG stock opened at $580.18 on Friday. The company has a market cap of $206.65 billion, a price-to-earnings ratio of 93.28, a PEG ratio of 5.19 and a beta of 1.39. The business has a fifty day simple moving average of $549.32 and a 200-day simple moving average of $507.50. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Bennett Selby Investments LP increased its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. LVW Advisors LLC increased its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the last quarter. FSM Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC increased its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.